Semantic Scholar uses AI to extract papers important to this topic.
Arsenicals and antimonials are first line drugs for the treatment of trypanosomal and leishmanial diseases. To create the active… Expand ABSTRACT In both scid and BALB/c mouse-Leishmania donovani models, hexadecyphosphocholine (miltefosine) and AmBisome had similar… Expand A quantitative colorimetric assay using the oxidation-reduction indicator Alamar Blue was developed to measure cytotoxicity of… Expand Successful treatment in allergic, autoimmune, and infectious diseases often requires altering the nature of a detrimental immune… Expand Pentavalent antimonial compounds have been the mainstay of the treatment of visceral, cutaneous, and mucosal leishmaniasis for… Expand To determine the relative efficacy and toxicity of stibogluconate and ketoconazole for the treatment of cutaneous leishmaniasis… Expand We report that in vitro sensitivity to pentavalent antimony (Sb5) of 35 Leishmania isolates as determined by the semiautomated… Expand Antimony unresponsiveness in mucocutaneous and visceral leishmaniasis is a serious clinical problem. Information on the… Expand We report the characterization of 6 Leishmania tropica isolates from 2 patients with visceral leishmaniasis who were unresponsive… Expand The 1980s have seen significant advances in the treatment of cutaneous, mucosal, and visceral leishmaniasis. Safe regimens of… Expand